Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
07/14/2004 | CN1512900A Aerosol forming device for use in inhalation therapy |
07/14/2004 | CN1512893A Use of antioxidant for treating and/or preventing surface ocular disorders |
07/14/2004 | CN1512890A HCG formulation |
07/14/2004 | CN1512884A 阿立哌唑口服溶液 Aripiprazole Oral Solution |
07/14/2004 | CN1512882A Reconstitutable parenteral composition containing COX-2 inhibitor |
07/14/2004 | CN1512877A Method for encapsulating active substance |
07/14/2004 | CN1512876A Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
07/14/2004 | CN1512875A Inhalation capsules |
07/14/2004 | CN1512872A Aerosol composition comprising silicate particles and surfactants |
07/14/2004 | CN1512860A Prosthetic foot with tunable performance |
07/14/2004 | CN1512859A Prosthetic foot with tunable performance |
07/14/2004 | CN1512858A Prosthetic foot with tunable performance |
07/14/2004 | CN1512845A Calorically dense liquid oral supplement |
07/14/2004 | CN1511848A Branched chain polyethylene glycol-integrated int3erferon composition and preparation |
07/14/2004 | CN1511828A Sufonic aniline derivatives and their medicinal use |
07/14/2004 | CN1511825A Process for preparing aromatic polyamine mixture |
07/14/2004 | CN1511589A Biological compactable medicine carrier and its preparing method |
07/14/2004 | CN1511586A Oral digestible film and its preparing process and use |
07/14/2004 | CN1511565A Method for producing sugar reducing extract granular agent |
07/14/2004 | CN1511560A Method for producing bed sore ointment |
07/14/2004 | CN1511542A Composition for improving obstacle under pharynx |
07/14/2004 | CN1511540A Use of scutellarin in preparing medicine for treating or preventing stomatocace |
07/14/2004 | CN1511532A Medical composition |
07/14/2004 | CN1511530A Use of ligustrazine in preparing medicine for treating penis erection dysfunction |
07/14/2004 | CN1511526A Rifaximin ointment |
07/14/2004 | CN1511524A Indapamide slow-releasing capsule and its preparing process |
07/14/2004 | CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated |
07/14/2004 | CN1511516A Protein and protein/phospholipid micro capsule and its preparing method |
07/14/2004 | CN1511515A Novel medicine slow releasing preparation and its preparing method |
07/14/2004 | CN1511514A Acetaminophen granule with slow releasing action and its preparing method |
07/14/2004 | CN1511510A High oil-coating type solid micro pill for preparing liquid oily medicine in liquid phase and is preparing method |
07/14/2004 | CN1511482A Food coated with sugar |
07/14/2004 | CN1157404C Novel fusidic acid derivatives |
07/14/2004 | CN1157229C Permanent-magnet colloid for plastic self-viscose magnetcally osmosizing ointment and its preparing process |
07/14/2004 | CN1157228C Method for the production of tablets by pressing and tablets produced by the method |
07/14/2004 | CN1157227C Use of low molecular weight amino alcohols in ophthalmic compositions |
07/14/2004 | CN1157217C Spraying medicine for treating tinea pedis and process for making same |
07/14/2004 | CN1157216C Toxic substance removing ointment and its preparing method |
07/14/2004 | CN1157213C Chinese medicine composition for treating acute mastitis, mastroplasia and hysteromyoma |
07/14/2004 | CN1157205C Ointment for treating ostalgia |
07/14/2004 | CN1157200C Syrup and granules for treating laryngopharyngitis and preparation process thereof |
07/14/2004 | CN1157199C Chinese medicine for treating hyperosteogeny, arthritis and herniation of cervical disc and prolapse of lumbar intervartebral disc and administration device thereof |
07/14/2004 | CN1157195C Soft capsule of superfine compound pearl powder and its preparing process |
07/14/2004 | CN1157193C Lotion for treating anal fistula and gynopathy |
07/14/2004 | CN1157185C Protein stabilized pharmacologically active agents, methods for preparation thereof and methods for use thereof |
07/14/2004 | CN1157184C Application of liposome preparation in transferring foreign DNA by testis injection |
07/14/2004 | CN1157183C Calamine lotion |
07/14/2004 | CA2415318A1 Ekinagum |
07/13/2004 | US6762267 Adjusting bulk density; compact tableting |
07/13/2004 | US6761914 And an antigen that is preferably a recombinant fusion protein; from seeds from oilseed crops, such as soybean, rapeseed, sunflower and palm |
07/13/2004 | US6761912 Composition for increasing bone density |
07/13/2004 | US6761910 Sublingually administering a drug with a bioadhesion or mucoadhesion promoting compound; water soluble carrier particles; effective plasma levels within a short time; fentanyl analgesic |
07/13/2004 | US6761909 Compressed antisolvent fluid precipitates particles; organic cosolvent system; biocompatible polymer for pulmonary sustained insulin release; inhalant powder; solvent extraction |
07/13/2004 | US6761908 Mixture of acid insoluble fractions each having a different molecular weight; decomposition of calfskin with variable alkalinity and time; bioadhesives; wound healing |
07/13/2004 | US6761907 Coated dosage units |
07/13/2004 | US6761905 Subjecting mixture of diluent excipients and pharmaceutically active ingredient, binder excipient, optionally with disintegrant excipient, to heating under condition of low moisture and tumble rotation to form tablets |
07/13/2004 | US6761904 Pharmaceutical kit comprising midodrine as active drug substance |
07/13/2004 | US6761903 Solubilization of triglycerides, drug delivery |
07/13/2004 | US6761902 Surrounds an elloptiod ro spehrical shape which contains an attractant such as streptavidin or avidin and is anchored to to the protein; isolation and purification while maintaining in a wild-type conformation |
07/13/2004 | US6761901 Proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration. |
07/13/2004 | US6761900 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
07/13/2004 | US6761895 Drug delivery system for averting pharmacokinetic drug interaction and method thereof |
07/13/2004 | US6761879 Titanium derived compounds, preparation and use thereof |
07/13/2004 | CA2348882C Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol |
07/13/2004 | CA2286684C Controlled release formulations using intelligent polymers |
07/13/2004 | CA2260143C Anthelmintic formulations |
07/13/2004 | CA2259270C Pharmaceutical preparation containing nimesulide for oral administration |
07/13/2004 | CA2241963C Improved storage wrap material |
07/13/2004 | CA2108734C Polyurethane pressure-sensitive adhesives |
07/13/2004 | CA2067062C Infusion preparation |
07/08/2004 | WO2004056469A1 Pellets and method for production thereof |
07/08/2004 | WO2004056443A1 Apparatus and method for the isolation of produced particles as a suspension ina non-supercritical fluid |
07/08/2004 | WO2004056407A2 Biomedical devices with antimicrobial coatings |
07/08/2004 | WO2004056396A1 DOSAGE FORMS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS WITH IMPROVED PERFORMANCE |
07/08/2004 | WO2004056395A1 Compositions of cholesteryl ester transfer protein inhibitors and hmg-coa reductase inhibitors |
07/08/2004 | WO2004056393A1 Agent with a retarded release of substances |
07/08/2004 | WO2004056373A1 High dose ibandronate formulation |
07/08/2004 | WO2004056363A2 A physically and chemically stable nicotine-containing particulate material |
07/08/2004 | WO2004056359A1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
07/08/2004 | WO2004056358A1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
07/08/2004 | WO2004056357A1 Composition comprising diclofenac for treating otic pain and inflammation |
07/08/2004 | WO2004056356A1 Oil-acid emulsion and use thereof |
07/08/2004 | WO2004056354A1 Controlled release pharmaceutical compositions of tamsulosin |
07/08/2004 | WO2004056346A1 Methods and compositions for wound management |
07/08/2004 | WO2004056345A1 Disposable package for liquid, pasty or powder product |
07/08/2004 | WO2004056344A1 Slow release formulation of clarithromycin |
07/08/2004 | WO2004056343A1 Ingestible formulations for transient, noninvasive reduction of gastric volume |
07/08/2004 | WO2004056342A1 Process for preparing combination pharmaceutical formulations using supercritical fluids |
07/08/2004 | WO2004056341A1 Process for preparing pharmaceutical formulations using supercritical fluids |
07/08/2004 | WO2004056340A2 Stabilised solid drug dispersions in an organic carrier and a process for preparing the same |
07/08/2004 | WO2004056339A1 Method for producing agents which are to be administered orally and corresponding compositions using polymers and coatings thereof consisting of hydrophilic liquids |
07/08/2004 | WO2004056338A2 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
07/08/2004 | WO2004056337A2 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
07/08/2004 | WO2004056336A2 Controlled release, multiple unit drug delivery systems |
07/08/2004 | WO2004056335A2 Delivery device containing venlafaxine and memantine and use method thereof |
07/08/2004 | WO2004056323A2 Method of treating angiogenic tissue growth |
07/08/2004 | WO2004056320A2 Compositions of non-steroidal anti-inflammatory drugs decongestants and anti-histamines |
07/08/2004 | WO2004056314A2 Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity |
07/08/2004 | WO2004056311A2 Stimuli-responsive systems for controlled drug delivery |
07/08/2004 | WO2004056216A1 Method of inhibiting water content variation of composition and use thereof |